T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros, Stephen J. Forman(City Of Hope National Medical Center), Julie R. Ostberg(CTI BioPharma (United Kingdom)), Ravi Bhatia(University of Alabama at Birmingham), Christine E. Brown(City Of Hope National Medical Center), Michael C. Jensen(Seattle Children's Hospital), Brenda Chang(City Of Hope National Medical Center), William Bretzlaff(City Of Hope National Medical Center), Xiuli Wang(City of Hope), Renate Starr(City of Hope), Lihua E. Budde(City Of Hope National Medical Center), Mahesh Jonnalagadda(City Of Hope National Medical Center), Lauren Hoffman(City Of Hope National Medical Center), Wen-Chung Chang(City Of Hope National Medical Center), Tinisha McDonald, Cédric Dos Santos, Brenda Aguilar(City of Hope)
Cited by 373
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754